Palivizumab Biosimilar, Endotoxin 0.05 EU/mg. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human...
Panitumumab Biosimilar, N297A Mutant. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research use only (RUO). Recombinant human IgG2...
Panitumumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research use...
Panitumumab Biosimilar, Endotoxin 0.05 EU/mg. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research use only (RUO). Recombinant human...
Eculizumab Biosimilar, N297A Mutant. Eculizumab biosimilar CHO stable cell line is available for licensing to manufacture the eculizumab biosimilar protein. The research grade eculizumab biosimilar protein is for research use only (RUO). Recombinant human IgG4...
Eculizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Eculizumab biosimilar CHO stable cell line is available for licensing to manufacture the eculizumab biosimilar protein. The research grade eculizumab biosimilar protein is for research use...
Infliximab Biosimilar, N297A Mutant. Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab biosimilar protein is for research use only (RUO). Recombinant human IgG1...
Infliximab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab biosimilar protein is for research use...
Syd Labs Recombinant Human RANKL Protein BP000050-GD13, The activity of the RANKL protein (RANK ligand, TNFSF11, TRANCE, OPGL, CD254) is calculated by its ability to induce osteoclast differentiation on RAW 264.7 mouse macrophages. The ED50...
Syd Labs provides a variety of cheap research grade antibody biosimilar proteins starting from $30/mg.
